Keywords: Thioredoxins; Cholestasis; Oxidative stress; Cholangiocyte; ALT; Alanine aminotransferase; BDL; Bile duct ligation; GCLC; Gamma-glutamylcysteine; GSH; Reduced glutathione; GST; Glutathione S-Transferase; HO-1; Heme Oxygenase 1; 4-HNE; 4-hydroxy-2-nonenal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Intrahepatic cholestasis of pregnancy; Serum bile acid; Pseudo-targeted method; Metabolomics; UPLC-triple TOF-MS/MS; Diagnostic and therapeutic profiles; ICP; Intrahepatic cholestasis of pregnancy; TBA; total bile acids; UDCA; ursodeoxycholic acid; LCA; l
Keywords: AASLD; American Association for the Study of Liver Diseases; AIH; autoimmune hepatitis; AILDs; autoimmune liver diseases; BMD; bone mineral densitometry; CCA; cholangiocarcinoma; COIs; clinical outcome indicators; CRC; colorectal cancer; DAAs; direct acti
Keywords: AP; Alkaline phosphatase; BA; Biliary atresa; BASM; Biliary atresia splenic malformation; CMV; Cytomegalovirus; DDT; Duodenal tube test; EHBDs; Extrahepatic biliary ducts; ERCP; Endoscopic retrograde cholangiopancreatography; GB; Gallbladder; GGT; Gamma-g
Keywords: Biliary; Drainage; Surgery; Temporary Stent; ACCS; Amsterdam Cholestatic Complaints Score; ALP; alkaline phosphatase; ASGE; American Society for Gastrointestinal Endoscopy; AST; aspartate aminotransferase; CI; confidence interval; DS; dominant stricture;
Keywords: BA; bile acid; CA; cholic acid; CDCA; chenodeoxycholic acid; DCA; deoxycholic acid; DCD; diabetes-induced cognitive dysfunction; HFD; high-fat diet; LCA; lithocholic acid; MCA; muricholic acid; NC; normal control; MDCA; murideoxycholic acid; T-BA; taurine
Keywords: Metabolism; DCA; Infection; Microbiome; BW; body weight; CONV-Biota; conventionalized microbiota; Aero-Biota; aerobic CONV-Biota; Anaero-Biota; anaerobic CONV-Biota; CA; cholic acid; CFU; colony-forming unit; DCA; deoxycholic acid; FISH; fluorescence in s
Keywords: UDCA; ursodeoxycholic acid;
Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: ASBT; apical sodium-dependent bile acid transporter; BMI; body mass index; CA; cholic acid; CA-D4; cholic acidâ2,2,4,4âD4; CARB; Carbohydrate and Related Biomarkers; CDCA; chenodeoxycholic acid; CRP; C-reactive protein; CV; coefficient of variation; D
Keywords: ASBT; apical sodium-dependent bile acid transporter; ASDs; amorphous solid dispersions; BACS; bile acid-CoA synthase; BAT; bile acid-amino acid transferase; BCS; biopharmaceutics classification system; BSH; bile salt hydrolase; C4; 7α-hydroxy-4-cholesten
Keywords: Lipid; Metabolism; Myopathy; Diet; ABHD5; α/β-Hydrolase Domain-5; AC; adenylate cyclase; anti-ACVR2B; mouse monoclonal activin receptor type IIB; ATGL; adipose triglyceride lipase; BEZ; bezafibrate; CACT; carnitine translocase; CD36; cluster of differen
Keywords: Oxysterols; Cancer; Polymorphism; Risk; Genetics; Cholesterol; 25(OH)D; 25-hydroxyvitamin D; ABC; ATP-binding cassette; AEBS; antiestrogen-binding site; BC; breast cancer; BCR; biochemical recurrence; CETP; cholesteryl ester transfer protein; CH25H; chole
Keywords: UPLC-ESI-QTOFMS; ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry; CA; cholic acid; Ï-MCA; Ï-muricholic acid; β-MCA; β-muricholic acid; MDCA; murideoxycholic acid; UDCA; ursodeoxy
Keywords: LC-MS/MS; high-performance liquid chromatography-tandem mass spectrometry; BAs; bile acids; G-BAs; glycine-conjugated bile acids; T-BAs; taurine-conjugated bile acids; beta-MCA; beta-muricholic acid; CA; cholic acid; UDCA; ursodeoxycholic acid; HDCA; hy
Keywords: Bile acid biosynthesis; Inborn errors of metabolism; Mass spectrometry; CA; Cholic acid = 3α,7α,12α-trihydroxy-5β-cholanoic acid; CDCA; chenodeoxycholic acid = 3α,7α-dihydroxy-5β-cholanoic acid; UDCA; ursodeoxycholic acid = 3α,7β-dihydroxyc
Keywords: BA; bile acid; CA; cholic acid; CDCA; chenodeoxycholic acid; DCA; deoxycholic acid; LCA; lithocholic acid; UDCA; ursodeoxycholic acid; HDCA; hyodeoxycholic acid; MCA; muricholic acids (alpha [A], beta [B], gamma [G], omega [O]); T; taurine; G; glycine; HP
Keywords: Bile Acids; FXR; TGR5; Meta-Inflammation; apo; apolipoprotein; ASBT; apical sodiumâdependent bile acid transporter; BA; bile acid; BAS; bile acid sequestrant; BAT; brown adipose tissue; BSH; bile salt hydrolase; CA; cholic acid; CCK; cholecystokinin; CD
Keywords: 3-BC; 3-benzylidene camphor; 4-MBC; 4-methylbenzylidene camphor; Aβ; amyloid-β; ABAD; Aβ-binding alcohol dehydrogenase; AD; Alzheimer's disease; AI; aromatase inhibitor; AKR; aldo-keto reductase; AME; apparent mineralocorticoid excess; AR; androgen r
Keywords: Cystic fibrosis liver disease; CFLD; Ursodeoxycholic acid; UDCA; Transient elastography; TE; Cystic fibrosis liver disease; Ursodeoxycholic acid; Liver stiffness measurement; Fibroscan;
Keywords: ACR; acute cellular rejection; AFLP; acute fatty liver of pregnancy; BCS; Budd-Chiari syndrome; HELLP; haemolysis, elevated liver enzymes and low platelets syndrome; HEV; hepatitis E virus; HBsAg; hepatitis B surface antigen; HCV; hepatitis C virus; HG; h
Keywords: Dysplasia; Surveillance; Thiopurines; Bile Duct Tumor; Immunosuppressant; AIH; autoimmune hepatitis; CCA; cholangiocarcinoma; HCC; hepatocellular carcinoma; IBD; inflammatory bowel disease; PSC; primary sclerosing cholangitis; Q; quartile; UDCA; ursodeoxy
Keywords: ABCB; ATP-binding cassette sub-family B; Apo; apolipoprotein; ASBT; apical sodium dependent bile acid transporter; BDL; bile duct ligation; BSEP; bile salt export pump; CA; cholic acid; CDCA; chenodeoxycholic acid; C/EBP; CCAAT-enhancer-binding protein; C
Keywords: AILD; autoimmune liver disease; PBC; primary biliary cirrhosis; AIH; autoimmune hepatitis; PSC; primary sclerosing cholangitis; UDCA; ursodeoxycholic acid; OCA; obeticholic acid; HCV; hepatitis C virus; ALP; alkaline phosphatase; APRI; aspartate transamin
Keywords: Cholestasis; Autoimmune Liver Disease; Prognosis; Predictive Factor; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; NRI; net reclassification improvement; PBC; primary biliary cirrhosis; UDCA; ursodeoxycholic acid
Keywords: BDL; bile duct ligation; Mmp; matrix metalloproteinases; Timp; tissue inhibitors of metalloproteinase; NqoI; NAD(P)H quinone oxidoreductase; UDCA; ursodeoxycholic acid; PBC; primary biliary cirrhosis; GSH; glutathione; Mrp; multidrug resistance-associated
Keywords: CA; cholic acid; CDCA; chenodeoxycholic acid; CID; collision-induced dissociation; DCA; deoxycholic acid; ESI; electrospray ionization; GlcNAc; N-acetylglucosamine; LC; liquid chromatography; LCA; lithocholic acid; MS; mass spectrometry; MS/MS; tandem mas
Keywords: Bariatric Surgery; Cholelithiasis; Cholesterol; Obesity; BMI; body mass index; CI; confidence interval; CSI; cholesterol saturation index; LCD; low calorie diet; NNT; number needed to treat; RCT; randomized controlled trial; RR; risk ratio; UDCA; ursodeox
Keywords: FibroScan; Surrogate Marker; Prognosis; Survival; ACC; accuracy; AIH; autoimmune hepatitis; ALP; alkaline phosphatase; APRI; aspartate aminotransferase/platelet ratio index; AST; aspartate aminotransferase; AUROC; area under the receiver-operating charact
Keywords: Autoimmune Liver Disease; Response To Treatment; Biomarker; New Therapies; CI; confidence interval; HR; hazard ratio; PBC; primary biliary cirrhosis; UDCA; ursodeoxycholic acid; ULN; upper limit of normal;
Keywords: ABC; ATP-binding cassette; AE2 (SLC4A2); anion exchanger 2; ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; ALP; alkaline phosphatase; ASBT (SLC10A2); apical sodium-dependent bile acid transporter; ASCOM; activating signal cointegrator-
Keywords: ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Keywords: PSC; primary sclerosing cholangitis; UC; ulcerative colitis; CRC; colorectal cancer; IBD; inflammatory bowel disease; CD; Crohn's disease; 5-ASA; 5-amynosalicilates; LGD; low-grade dysplasia; HGD; high-grade dysplasia; UDCA; ursodeoxycholic acid; Ulcerati
Keywords: LPAC; low phospholipid associated cholelithiasis; PFIC; progressive familial intrahepatic cholestasis; UDCA; ursodeoxycholic acid therapy; ABCB4 gene; ABCB11 gene; Protein MDR3; Ursodeoxycholic acid therapy;
Keywords: ICP; intrahepatic cholestasis of pregnancy; OR; odds ratio; aOR; adjusted odds-ratio; CI; confidence interval; CS; cesarean section; MBR; Swedish Medical Birth Register; BMI; body mass index; UDCA; ursodeoxycholic acid; Intrahepatic cholestasis of pregnan
Keywords: UDCA; NaDOC; Intestinal Ca2+ absorption; Ca2+-ATPase; Na+/Ca2+ exchanger; Calbindin D28k;
Keywords: HE; hepatic encephalopathy; MELD; model for end-stage liver disease; BA; bile acid; CA; cholic acid; CDCA; chenodeoxycholic acid; LCA; lithocholic acid; DCA; deoxycholic acid; UDCA; ursodeoxycholic acid; GBA; glycine conjugated bile acid; TBA; taurine con
Keywords: PBC; primary biliary cirrhosis; CMVs; canalicular membrane vesicles; mAb1F9; monoclonal antibody 1F9; mAb1F9-Ag; mAb1F9 antigen; UDCA; ursodeoxycholic acid; MALDI-TOF/TOF; matrix assisted laser desorption/ionization-tandem time-of-flight analysis; MS; mas
Keywords: di-4-ANEPPDHQ; 1-[2-Hydroxy-3-(N,N-di-methyl-N-hydroxyethyl)ammoniopropyl]-4-[β-[2-(di-n-butylamino)-6-napthyl] vinyl]pyridinium dibromide; BA(s); Bile acid(s); Bax; Bcl-2-associated X protein; CDCA; Chenodeoxycholic acid; Chol; Cholesterol; DCA; Deoxych
Keywords: BH; Bcl-2 homology; CA; cholic acid (3α,7α,12α-trihydroxy-5β-cholanoic acid); CDCA; chenodeoxycholic acid (3α,7α-dihydroxy-5β-cholanoic acid); DCA; deoxycholic acid (3α,12α-dihydroxy-5β-cholanoic acid); EGFR; epidermal growth factor receptor; ER
Keywords: AFm; mono aluminate ferrite; A549; adenocarcinomic human alveolar basal epithelial cell line; C3A; tricalcium aluminate; C4AF; tetracalcium aluminoferrite; CEC; cationic exchange capacity; CLA; conjugated linoleic acids; CNT; carbon nanotubes; DBS; dodecy
The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats
Keywords: Asbt; apical sodium-dependent bile acids transporter; ALP; alkaline phosphatase; ALT; alanine transaminase; AST; aspartate transaminase; BAs; bile acids; Bsep/BSEP; bile salt export pump; β-MCA; β-muricholic acid; CA; cholic acid; CDCA; chenodeoxycholic
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Keywords: FOLD Consortium; Epidemiology; Racial Disparities; Gender; Autoimmune Disease; aAPC; adjusted annual percentage change; aHR; adjusted hazard ratio; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AMA; antimitochondrial antibody; APC; annual per
Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models
Keywords: ALT; alanine transferases; ALP; alkaline phosphatase; BA; bile acid; bcoA; butyryl-coenzyme-A-CoA transferase; buk; butyrate kinase; B. infantis; Bifidobacterium longum subsp. infantis; CA; cholic acid; CDCA; chenodeoxycholic acid; DCA; deoxycholic acid;
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems
Keywords: Primary Biliary Cirrhosis; Classification and Regression Trees; Electronic Health Records; Racial Disparities; Gender; Autoimmune Disease; ALP; alkaline phosphatase; AMA; antimitochondrial antibody; ASINPI; Asian American, American Indian, or Pacific Isla
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites
Keywords: Bacteria; Intestine; Metabolomics; Colitis; AEA; arachidoyl ethanolamide; 3AIBA; 3-aminoisobutyric acid; BHIS; brain heart infusion-supplemented; CDI; Clostridium difficile infection; CSA13; cationic steroid antimicrobial 13; FMT; fecal microbiota trans
Genetic determinants of cholangiopathies: Molecular and systems genetics
Keywords: AP; alkaline phosphatase; ASBT; apical sodium bile acid transporter; BRIC; benign recurrent intrahepatic cholestasis; CC; collaborative cross; DILI; drug-induced liver injury; ɣ-GT; ɣ-glutamyl transpeptidase; GRP; genetic reference populations; GWAS; ge
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations
Keywords: NR; nuclear receptor; FXR; farnesoid X receptor; RXR; retinoid X receptor; PXR; pregnane X receptor; VDR; Vitamin D receptor; TGR5; G protein-coupled bile acid receptor; Lrh1; liver receptor homolog 1; Mdr; multidrug resistance protein; Abcb4; ATP Bindi
Transhepatic bile acid kinetics in pigs and humans
Keywords: Bile acids; TGR5; Porcine; Postprandial; Portal concentrations; BAs; bile acids; ASBT; apical sodium-dependent bile acid transporter; OST; organic solute transporter; NTCP; taurocholate cotransporting polypeptide; OATP; organic anion transporting polypept
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer
Keywords: FXR; Obeticholic Acid; S-Adenosylmethionine; Ursodeoxycholic Acid; AP-1; activator protein-1; ARE; antioxidant response element; BDL; bile duct ligation; BrdU; 5-bromo-2'deoxyuridine; CCA; cholangiocarcinoma; FXR; farnesoid X receptor; GSH; reduced glut